BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 38680092)

  • 1. Roles of TRPM channels in glioma.
    Chen Z; Xie H; Liu J; Zhao J; Huang R; Xiang Y; Wu H; Tian D; Bian E; Xiong Z
    Cancer Biol Ther; 2024 Dec; 25(1):2338955. PubMed ID: 38680092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
    Liu M; Inoue K; Leng T; Guo S; Xiong ZG
    Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function and pharmacology of TRPM cation channels.
    Harteneck C
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Apr; 371(4):307-14. PubMed ID: 15843919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPM channels in health and disease.
    Chubanov V; Köttgen M; Touyz RM; Gudermann T
    Nat Rev Nephrol; 2024 Mar; 20(3):175-187. PubMed ID: 37853091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.
    Bao MH; Lv QL; Szeto V; Wong R; Zhu SZ; Zhang YY; Feng ZP; Sun HS
    J Cell Physiol; 2020 May; 235(5):4594-4604. PubMed ID: 31637708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
    Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
    Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.
    Leng TD; Li MH; Shen JF; Liu ML; Li XB; Sun HW; Branigan D; Zeng Z; Si HF; Li J; Chen J; Xiong ZG
    CNS Neurosci Ther; 2015 Mar; 21(3):252-61. PubMed ID: 25438992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory interplay between microRNAs and WNT pathway in glioma.
    Tabnak P; Mafakheri A; Haji Emsailpoor Z; Kazemi T; Shekari N
    Biomed Pharmacother; 2021 Nov; 143():112187. PubMed ID: 34560532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances of long non-coding RNAs mediated by wnt signaling in glioma.
    Han W; Shi J; Cao J; Dong B; Guan W
    Pathol Res Pract; 2020 Aug; 216(8):153008. PubMed ID: 32703485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TRPM2 in brain tumours and potential as a drug target.
    Ji D; Luo ZW; Ovcjak A; Alanazi R; Bao MH; Feng ZP; Sun HS
    Acta Pharmacol Sin; 2022 Apr; 43(4):759-770. PubMed ID: 34108651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNAs: Functions and Prospects in Glioma.
    Hao Z; Hu S; Liu Z; Song W; Zhao Y; Li M
    J Mol Neurosci; 2019 Jan; 67(1):72-81. PubMed ID: 30460608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell death modulation by transient receptor potential melastatin channels TRPM2 and TRPM7 and their underlying molecular mechanisms.
    Shi R; Fu Y; Zhao D; Boczek T; Wang W; Guo F
    Biochem Pharmacol; 2021 Aug; 190():114664. PubMed ID: 34175300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PIEZO1 as a potential prognostic marker in gliomas.
    Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
    Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC Channels and Glioma.
    Li S; Ding X
    Adv Exp Med Biol; 2017; 976():157-165. PubMed ID: 28508321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of TRPM in melanocytes and melanoma.
    Guo H; Carlson JA; Slominski A
    Exp Dermatol; 2012 Sep; 21(9):650-4. PubMed ID: 22897572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPM2 Channels: A Potential Therapeutic Target in Melanoma?
    Foster HM; Carle MN; Jira LR; Koh DW
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
    Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
    Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential roles of aquaporin 4 in malignant gliomas.
    Lan YL; Wang X; Lou JC; Ma XC; Zhang B
    Oncotarget; 2017 May; 8(19):32345-32355. PubMed ID: 28423683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Ion Channels for the Treatment of Glioma.
    Keluth S; Jitte S; Bhushan R; Ranjan OP; Murti K; Ravichandiran V; Kumar N
    Mini Rev Med Chem; 2023; 23(12):1298-1318. PubMed ID: 36809933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.